CFTR and cystic fibrosis: Among CFTR modulators, the combination Elexacaftor/Tezacaftor/Ivacaftor (ETI) is currently available for children with CF who carry at least one F508del variant, and leads to significant improvement in lung function tests and quality of life indicators from 6 years of age.